Researchers at Karolinska Institutet have developed a way that allows environment friendly supply of therapeutic proteins and RNA to cells. The strategy, printed in Nature Communications, reveals promising leads to animal research to ship gene editors and protein therapeutics.
The strategy is predicated on so-called extracellular vesicles (EVs), tiny bubbles which might be naturally secreted by cells and might transport biologically energetic molecules between cells. Researchers have now succeeded in bettering these bubbles by introducing two key elements: a small a part of a bacterial protein known as intein and a so-called fusogenic protein from a virus.
The fusogenic protein helps the bubbles to fuse with the endosomal membrane and launch their contents into the cell, whereas the intein can reduce itself and thus assist launch therapeutic proteins contained in the cell.
“This progressive engineering technique represents a serious step ahead for extracellular vesicle expertise, successfully overcoming key limitations corresponding to poor endosomal escape and restricted intracellular launch,” says Professor Samir EL Andaloussi, final writer of the examine and researcher on the Division of Laboratory Medication.
“Our in vivo findings spotlight the potential of engineered EVs as a flexible platform for delivering therapeutics to deal with a broad vary of situations, together with systemic irritation, genetic illnesses, and neurological issues.”
The examine’s first writer, Dr. Xiuming Liang on the Division of Laboratory Medication, provides, “By bettering the effectivity and reliability of therapeutic supply into goal cells, this expertise may considerably broaden the applying of superior medicines.”
Mind adjustments in mice
In experiments on cells and reside animals, the researchers have been capable of effectively ship Cre recombinase, a protein that may reduce and paste DNA, and Cas9/sgRNA complexes, that are used to edit genes. When extracellular vesicles loaded with Cre recombinase have been injected into the brains of mice, a major change in cells within the hippocampus and cortex mind constructions was noticed.
“This provides hope to make use of the CRISPR/Cas9 gene scissors or comparable instruments to deal with extreme genetic illnesses of the central nervous system, corresponding to Huntington’s illness and spinal muscular atrophy,” says Liang.
The researchers additionally demonstrated that the approach may very well be used to deal with systemic irritation in mice.
Extra info: Xiuming Liang et al, Engineering of extracellular vesicles for environment friendly intracellular supply of multimodal therapeutics together with genome editors, Nature Communications (2025). DOI: 10.1038/s41467-025-59377-y. www.nature.com/articles/s41467-025-59377-y
